{"member_organisations": "", "identification_number": "547949121038-83", "fields_of_interest": "Agriculture, Maritime affairs and fisheries, Research and innovation, Public Health, Food Safety", "head_office_address": "5200 Illumina Way", "full_time_equivalent_fte": "0,5", "person_with_legal_responsibility": "Marc Stapley", "inter_groups": "", "financial_year_start_date": "01/01/2017", "grants": "", "head_office_country": "United States", "eu_initiatives": "Illumina follows policy and legislative developments related to genomics, agri-genomics, public health, animal health, agriculture, forensics, biotechnology, data protection, science, and research policies. \n \nIn particular, Illumina follows the discussions on the proposal for a Regulation on Health Technology Assessment and developments relating to the Regulations on medical devices and In-vitro diagnostics. \n \nIt also engages in policy and regulatory initiatives relating to research and innovation in the EU, including more generally developments relating to Horizon 2020 and future EU research programs, with a focus on genomics research. \n \nIllumina has an interest in regulatory developments on the exchange of personal data.  It monitors developments relating to the transfer of personal data from the EU to third countries (e.g., the EU-U.S. Privacy Shield) and digital health.", "organisation_name": "Illumina, Inc.", "belgium_office_post_code": "", "number_of_persons_involved": "2", "procurement": "", "section": "II - In-house lobbyists and trade/business/professional associations", "source": "", "belgium_office_address": "", "subsection": "Companies & groups", "belgium_office_phone": "", "number_of_ep_accredited_persons": "1", "overall_budget_turnover_as_a_range": "", "belgium_office_city": "", "persons_accredited_for_access_to_european_parliament_premises": "GARGESI#Miriam", "estimate_of_costs_absolute_amount": "", "registration_date": "11/03/2016", "website_address": "http://www.illumina.com", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "CA 92122", "head_office_city": "San Diego", "membership": "", "head_office_post_code": "", "goals__remit": "Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.", "industry_forums": "", "head_office_phone": "(+1)858 2024500", "level_of_interest": "global", "relevant_communication": "Illumina is engaging with EU policy makers in the EU institutions on its areas of interest.", "financial_year_end_date": "01/12/2017", "estimate_of_costs_as_a_range": "50000-99999", "overall_budget_turnover_absolute_amount": "0", "legal_status": "Corporation", "person_in_charge_of_eu_relations": "Miriam Gargesi", "customers": "", "belgium_office_post_box": "", "position": "Director Government Affairs EMEA"}